THERALINK TECHNOLOGIES, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2012 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Theralink Technologies, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2012 to Q3 2023.
  • Theralink Technologies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2023 was $15.4M, a 18.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $15.4M +$2.45M +18.9% Sep 30, 2023 10-K 2024-01-05
Q3 2022 $13M +$1.72M +15.3% Sep 30, 2022 10-K 2024-01-05
Q3 2021 $11.2M +$1.45M +14.9% Sep 30, 2021 10-K 2022-12-29
Q3 2020 $9.79M +$866K +9.7% Sep 30, 2020 10-K 2022-01-13
Q4 2019 $2.61M +$472K +22.1% Dec 31, 2019 10-K 2020-03-25
Q3 2019 $8.92M Sep 30, 2019 10-K 2021-09-27
Q4 2018 $2.13M +$647K +43.6% Dec 31, 2018 10-K 2020-03-25
Q4 2017 $1.49M +$379K +34.3% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $1.11M +$734K +197% Dec 31, 2016 10-K 2018-05-31
Q4 2015 $373K Dec 31, 2015 10-K 2017-04-17
Q1 2015 $807K -$226K -21.9% Feb 28, 2015 10-K 2015-05-29
Q1 2014 $1.03M +$189K +22.4% Feb 28, 2014 10-K 2015-05-29
Q1 2013 $844K +$1.62M Feb 28, 2013 10-K 2014-06-13
Q4 2012 -$634K Nov 30, 2012 10-Q 2013-01-22
Q3 2012 -$504K Aug 31, 2012 10-Q 2012-10-15
Q1 2012 -$777K Feb 29, 2012 10-K 2013-06-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.